Geriatric palliative care - Part I: Pain and symptom management

Clinical Geriatrics

Volumn 15, Issue 1, 2007, Pages 25-32

  Bishop, Tara F ^a   Morrison, Sean ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BRONCHODILATING AGENT; CARBAMAZEPINE; CITALOPRAM; CODEINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DESIPRAMINE; DULOXETINE; FENTANYL; GABAPENTIN; HYDROMORPHONE; LAMOTRIGINE; LAXATIVE; LIDOCAINE; MEGESTROL ACETATE; METHYLPHENIDATE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; OXYCODONE; OXYGEN; PARACETAMOL; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ADRENAL INSUFFICIENCY; ANOREXIA; ARTICLE; BLURRED VISION; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CHRONIC PAIN; CLINICAL TRIAL; CONFUSION; CONSTIPATION; DEEP VEIN THROMBOSIS; DELIRIUM; DEPRESSION; DRUG ABSORPTION; DRUG DOSE INCREASE; DRUG FATALITY; DYSPNEA; EDEMA; FATIGUE; FECES IMPACTION; GASTROINTESTINAL SYMPTOM; GERIATRIC CARE; HEALTH CARE NEED; HEALTH CARE SYSTEM; HOT FLUSH; HUMAN; HYPERACTIVITY; INTERPERSONAL COMMUNICATION; LUNG EMBOLISM; MEDICAL CARE; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; NAUSEA; NEUROPATHIC PAIN; OPIATE ADDICTION; ORTHOSTATIC HYPOTENSION; OXYGEN THERAPY; PAIN; PAIN ASSESSMENT; PALLIATIVE THERAPY; PATIENT DECISION MAKING; PRURITUS; QUALITY OF LIFE; RESTLESSNESS; SEDATION; SIDE EFFECT; SOMNOLENCE; SUSTAINED RELEASE FORMULATION; SYMPTOMATOLOGY; TACHYPHYLAXIS; TEAMWORK; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; URINE RETENTION;

EID: 33846892491     PISSN: 10951598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Morrison RS, Meier DE. Clinical practice. Palliative care. N Engl J Med 2004;350(25):2582-2590.
2. American Academy of Hospice and Palliative Medicine, Center to Advance Palliative Care, Hospice and Palliative Nurses Association, Last Acts Partnership, and National Hospice and Palliative Care Organization. National Consensus Project for Quality Palliative Care: Clinical Practice Guidelines for quality palliative care, executive summary. J Palliat Med 2004;7(5):611-627.
3. Singer PA, Martin DK, Kelner M. Quality end-of-life care: Patients' perspectives. JAMA 1999;281(2):163-168.
4. The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 1995; 274(20):1591-1598.
5. Emanuel EJ, Fairclough DL, Slutsman J, Emanuel LL. Understanding economic and other burdens of terminal illness: The experience of patients and their caregivers. Ann Intern Med 2000;132(6):451-459.
6. Field MJ, Cassel CK; Institute of Medicine Committee on Care at the End of Life, Institute of Medicine. Approaching Death: Improving Care at the End of Life. Washington, D.C.: National Academy Press; 1997.
7. AGS Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc 2002;50(6 suppl):S205-S224.
8. Warfield CA, Bajwa ZH, eds. Principles and Practice of Pain Medicine. New York, NY; McGraw-Hill, Medical Pub. Div; 2004.
9. Won A, Lapane K, Gambassi G, et al. Correlates and management of nonmalignant pain in the nursing home. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. J Am Geriatr Soc 1999;47(8):936-942.
10. Miller SC, Mor V, Wu N, et al. Does receipt of hospice care in nursing homes improve the management of pain at the end of life? J Am Geriatr Soc 2002;50(3):507-515.
11. Won AB, Lapane KL, Vallow S, et al. Persistent nonmalignant pain and analgesic prescribing patterns in elderly nursing home residents. J Am Geriatr Soc 2004;52(6):867-874.
12. Herr KA, Garand L. Assessment and measurement of pain in older adults. Clin Geriatr Med 2001;17(3):457-78, vi.
13. Warden V, Hurley AC, Volicer L. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc 2003;4(1):9-15.
14. Ferrell BA, Ferrell BR, Rivera L. Pain in cognitively impaired nursing home patients. J Pain Symptom Manage 1995;10(8):591-598.
15. Weiner D, Peterson B, Keefe F. Chronic pain-associated behaviors in the nursing home: Resident versus caregiver perceptions. Pain 1999;80(3):577-588.
16. Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 2004;5(2):133-137.
17. Goldstein NE, Morrison RS. Treatment of pain in older patients. Crit Rev Oncol Hematol 2005;54(2):157-164.
18. Brophy JM. Cardiovascular risk associated with celecoxib. N Engl J Med 2005;352(25):2648-2650.
19. Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain 2002; 18(4 suppl):S3-S13.
20. Morrison RS, Magaziner J, Gilbert M, et al. Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci 2003;58(1):76-81.
21. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2005;(3):CD005454.
22. Small GW. Tricyclic antidepressants for medically ill geriatric patients. J Clin Psychiatry 1989;50(suppl):27-33.
23. Sindrup SH, Bjerre U, Dejgaard A, et al. The selective serotonin reuptake inhibitor citolopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992;52(5):547-552.
24. Sindrup SH, Gram LF, Brosen K, et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990;42(2):135-144.
25. Lussier D, Huskey AG, Portenoy RK. Adjuvant analgesics in Cancer pain management. Oncologist 2004;9(5):571-591.
26. Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: A double-blind, placebo-controlled study. Pain 2004;110(3):697-706.
27. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003;60(11):1524-1534.
28. McCleane GJ. Lamotrigine in the management of neuropathic pain: A review of the literature. Clin J Pain 2000;16(4):321-326.
29. Gammaitoni AR, Alvarez NA, Galer BS. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: A review of the literature. J Clin Pharmacol 2003;43(2):111-117.
30. Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer 2000;88(9):2164-2171.
31. Chang VT, Hwang SS, Kasimis B, Thaler HT. Shorter symptom assessment instruments: The Condensed Memorial Symptom Assessment Scale (CMSAS). Cancer Invest 2004;22(4):526-536.
32. Plonk WM Jr, Arnold RM. Terminal care: the last weeks of life. J Palliat Med 2005;8(5):1042-1054.
33. Booth S, Wade R, Johnson M, et al; Expert Working Group of the Scientific Committee of the Association of Palliative Medicine. The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med 2004;98(1):66-77. [Erratum in: Respir Med 2004;98(5):476.]
34. Bruera E, MacEachern T, Ripamonti C, Hanson J. Subcutoneous morphine for dyspnea in cancer patients. Ann Intern Med 1993;119(9):906-907.
35. Abernethy AP, Currow DC, Frith P, et al. Randomised double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003;327(7414):523-528.
36. Chandler S. Nebulized opioids to treat dyspnea. Am J Hosp Palliat Care 1999;16(1):418-422.
37. Morrow GR, Shelke AR, Roscoe JA, et al. Management of cancer-related fatigue. Cancer Invest 2005;23(3):229-239.
38. Bruera E, Driver L, Barnes EA, et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: A preliminary report. J Clin Oncol 2003;21(23):4439-4443.
39. Galynker I, Ieronimo C, Miner C, et al. Methylphenidate treatment of negative symptoms in patients with dementia. J Neuropsychiatry Clin Neurosci 1997;9(2):231-239.
40. Bruera E, Roca E, Cedaro L, et al. Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study. Cancer Treat Rep 1985;69(7-8):751-754.
41. Berenstein EG, Ortiz Z. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev 2005;(2):CD004310.
42. Quigley EM, Hasler WL, Parkman HP. AGA technical review on nausea and vomiting. Gastroenterology 2001;120(1):263-286.
43. Lyness JM. End-of-life care: Issues relevant to the geriatric psychiatrist. Am J Geriatr Psychiatry 2004;12(5):457-472.
44. Chochinov HM, Tataryn D, Clinch JJ, Dudgeon D. Will to live in the terminally ill. Lancet 1999;354(9181):816-819.
45. Lyness JM, Caine ED, King DA, et al. Depressive disorders and symptoms in older primary care patients: One-year outcomes. Am J Geriatr Psychiatry 2002;10(3):275-282.
46. Rozans M, Dreisbach A, Lertora JJ, Kahn MJ. Palliative uses of methyl-phenidate in patients with cancer: A review. J Clin Oncol 2002;20(1):335-339.
47. Conill C, Verger E, Henriquez I, et al. Symptom prevalence in the last week of life. J Pain Symptom Manage 1997;14(6):328-331.
48. Michaud L, Burnand B, Stiefel F. Taking care of the terminally ill cancer patient: Delirium as a symptom of terminal disease. Ann Oncol 2004;15 (suppl 4):iv, 199-203.
49. Casarett DJ, Inouye SK; American College of Physicians-American Society of Internal Medicine End-of-Life Care Consensus Panel. Diagnosis and management of delirium near the end of life. Ann Intern Med 2001;135(1):32-40.
50. Jackson KC, Lipman AG. Drug therapy for delirium in terminally ill patients. Cochrane Database Syst Rev 2004;(2):CD004770.
51. Breitbart W, Marotta R, Platt MM, et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996;153(2):231-237.
52. Daniel DG. Antipsychotic treatment of psychosis and agitation in the elderly. J Clin Psychiatry 2000;61(suppl 14):49-52.
53. Quill TE, Byock IR. Responding to intractable terminal suffering: The role of terminal sedation and voluntary refusal of food and fluids. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians-American Society of Internal Medicine. Ann Intern Med 2000;132(5):408-414. [Erratum in: Ann Intern Med 2000;132(12):1011.]
54. Lo B, Rubenfeld G. Palliative sedation in dying patients: "We turn to it when everything else hasn't worked." JAMA 2005; 294(14):1810-1816.